Literature DB >> 6597553

The adenoma-carcinoma sequence.

D W Day.   

Abstract

The adenoma-carcinoma sequence refers to the development of malignant change in a precursor focal dysplastic polypoid lesion, the adenoma. In the intestinal tract of man this progression has been most clearly documented in the large bowel and although the evidence is largely circumstantial, it would appear that the majority of malignant tumours at this site arise in this way. By contrast this course is unusual in the stomach, the other major site of gut malignancy, where adenomas are uncommon. Small intestinal adenocarcinoma is rare but there is evidence that a significant proportion of these tumours develop from a precursor adenoma. In the large bowel, adenomas are very common lesions in those populations where there is a high incidence of colorectal cancer. The likelihood of malignancy developing in an adenoma is related to increasing size, a villous as opposed to a tubular growth pattern, and the severity of cytological and architectural abnormalities (dysplasia) of the epithelium.

Entities:  

Mesh:

Year:  1984        PMID: 6597553

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  10 in total

1.  Plasminogen activators in experimental colorectal neoplasia: a role in the adenoma-carcinoma sequence?

Authors:  J S Gelister; M R Lewin; H E Driver; F Savage; M Mahmoud; P J Gaffney; P B Boulos
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

Review 2.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Dose dependent inhibitory effect of dietary caraway on 1,2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats.

Authors:  Kumaraswami Deeptha; Muthaiyan Kamaleeswari; Murugan Sengottuvelan; Namasivayam Nalini
Journal:  Invest New Drugs       Date:  2006-11       Impact factor: 3.850

Review 4.  Diagnosis, epidemiology and management of serrated polyposis syndrome: a comprehensive review of the literature.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Dimitrios K Christodoulou
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 5.  Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer.

Authors:  D Turner; H J Berkel
Journal:  CMAJ       Date:  1993-09-01       Impact factor: 8.262

Review 6.  Progression: the terminal stage in carcinogenesis.

Authors:  H C Pitot
Journal:  Jpn J Cancer Res       Date:  1989-07

7.  Hypermethylation of PDX1, EN2, and MSX1 predicts the prognosis of colorectal cancer.

Authors:  Yeongun Lee; So Hee Dho; Jiyeon Lee; Ji-Hyun Hwang; Minjung Kim; Won-Young Choi; Jin-Young Lee; Jongwon Lee; Woochul Chang; Min Young Lee; Jungmin Choi; Tae-You Kim; Lark Kyun Kim
Journal:  Exp Mol Med       Date:  2022-02-15       Impact factor: 12.153

8.  v-src transformation of rat embryo fibroblasts. Inefficient conversion to anchorage-independent growth involves heterogeneity of primary cultures.

Authors:  N Tavoloni; H Inoue; H Sabe; H Hanafusa
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

9.  Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis.

Authors:  G Caderni; A Giannini; L Lancioni; C Luceri; A Biggeri; P Dolara
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

Review 10.  Serrated neoplasia in the colorectum: gut microbiota and molecular pathways.

Authors:  Xing Kang; Ru Zhang; Thomas Ny Kwong; Rashid Ns Lui; William Kk Wu; Joseph Jy Sung; Jun Yu; Sunny H Wong
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.